{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:34:01Z","timestamp":1773894841447,"version":"3.50.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01623-8","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T10:18:00Z","timestamp":1743675480000},"page":"5039-5056","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Uncovering somatic genetic drivers in prostate cancer through comprehensive genome-wide analysis"],"prefix":"10.1007","volume":"47","author":[{"given":"Lede","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0730-9989","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"issue":"3","key":"1623_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1623_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/cancers11030352","volume":"11","author":"P Nombela","year":"2019","unstructured":"Nombela P, Lozano R, Aytes A, Mateo J, Olmos D, Castro E. BRCA2 and Other DDR Genes in Prostate Cancer. Cancers (Basel). 2019;11(3):352.","journal-title":"Cancers (Basel)"},{"key":"1623_CR3","doi-asserted-by":"crossref","unstructured":"Siegelmann-Danieli N, Neiman V, Bareket-Samish A, Berger R, Peretz A, Alapi H, Tsur E, Patalon T, Beller D, Rimler G, Chodick G, Shohat M. Whole exome germline sequencing in early-onset prostate cancer patients: genomic findings and clinical outcomes. Prostate. 2024;84(1):39\u201346.","DOI":"10.1002\/pros.24622"},{"issue":"11","key":"1623_CR4","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaoncol.2023.3482","volume":"9","author":"BF Darst","year":"2023","unstructured":"Darst BF, Saunders E, Dadaev T, Sheng X, Wan P, Pooler L, Xia LY, Chanock S, Berndt SI, Wang Y, Patel AV, Albanes D, Weinstein SJ, Gnanapragasam V, Huff C, Couch FJ, Wolk A, Giles GG, Nguyen-Dumont T, Milne RL, Pomerantz MM, Schmidt JA, Travis RC, Key TJ, Stopsack KH, Mucci LA, Catalona WJ, Marosy B, Hetrick KN, Doheny KF, MacInnis RJ, Southey MC, Eeles RA, Wiklund F, Conti DV, Kote-Jarai Z, Haiman CA. Germline sequencing analysis to inform clinical gene panel testing for aggressive prostate cancer. JAMA Oncol. 2023;9(11):1514\u201324.","journal-title":"JAMA Oncol."},{"issue":"5","key":"1623_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.euo.2023.07.008","volume":"6","author":"N Shore","year":"2023","unstructured":"Shore N, Gazi M, Pieczonka C, Heron S, Modh R, Cahn D, Belkoff LH, Berger A, Mazzarella B, Veys J, Idom C, Morris D, Jayram G, Engelman A, Bukkapatnam R, Dato P, Bevan-Thomas R, Cornell R, Wise DR, Hardwick MK, Hernandez RD, Rojahn S, Layman P, Hatchell KE, Heald B, Nussbaum RL, Nielsen SM, Esplin ED. Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial. Eur Urol Oncol. 2023;6(5):477\u201383.","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"1623_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/gcc.23190","volume":"62","author":"P Paulo","year":"2023","unstructured":"Paulo P, Cardoso M, Brand\u00e3o A, Pinto P, Falconi A, Pinheiro M, Cerveira N, Silva R, Santos C, Pinto C, Peixoto A, Maia S, Teixeira MR. Genetic landscape of homologous recombination repair genes in early-onset\/familial prostate cancer patients. Genes Chromosomes Cancer. 2023;62(12):710\u201320.","journal-title":"Genes Chromosomes Cancer."},{"issue":"5","key":"1623_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clgc.2023.05.012","volume":"21","author":"Y Ch\u00e1varri-Guerra","year":"2023","unstructured":"Ch\u00e1varri-Guerra Y, Bourlon MT, Rodr\u00edguez-Olivares JL, Orozco L, Bazua D, Rodr\u00edguez-Faure A, Alcalde-Castro MJ, Castro E, Castillo D, Herzog J, Weitzel J. Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer. Clin Genitourin Cancer. 2023;21(5):569\u201373.","journal-title":"Clin Genitourin Cancer"},{"issue":"7","key":"1623_CR8","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.21873\/anticanres.16465","volume":"43","author":"C Rocca","year":"2023","unstructured":"Rocca C, Rocca G, Zampieri P, Dell\u2019atti L, Bianchi N, Ippolito C, Aguiari G. Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer Res. 2023;43(7):2941\u20139.","journal-title":"Anticancer Res"},{"key":"1623_CR9","doi-asserted-by":"crossref","unstructured":"Grochot R, Carreira S, Miranda S, Figueiredo I, Bertan C, Rekowski J, Yuan W, Ferreira A, Riisnaes R, Neeb A, Gurel B, de Los Dolores Fenor de la Maza M, Guo C, Carmichael J, Westaby D, Mateo J, Sharp A, McVeigh TP, De Bono J. Germline ATM mutations detected by somatic DNA sequencing in lethal prostate cancer. Eur Urol Open Sci. 2023;52:72\u201378.","DOI":"10.1016\/j.euros.2023.04.003"},{"issue":"2","key":"1623_CR10","first-page":"133","volume":"52","author":"B Fang","year":"2023","unstructured":"Fang B, Wei Y, Pan J, Zhang T, Ye D, Zhu Y. Mismatch repair gene germline mutations in patients with prostate cancer. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52(2):133\u20138.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"1623_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109723","volume":"185","author":"JH Oh","year":"2023","unstructured":"Oh JH, Lee S, Thor M, Rosenstein BS, Tannenbaum A, Kerns S, Deasy JO. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients. Radiother Oncol. 2023;185: 109723.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1623_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.5534\/wjmh.220190","volume":"41","author":"SH Song","year":"2023","unstructured":"Song SH, Kim HM, Jung YJ, Kook HR, Jeon S, Bhak J, Kim JH, Lee H, Oh JJ, Lee S, Hong SK, Byun SS. Germline DNA-Repair Genes and HOXB13 Mutations in Korean Men with Metastatic Prostate Cancer: Data from a Large Korean Cohort. World J Mens Health. 2023;41(4):960\u20138.","journal-title":"World J Mens Health"},{"issue":"6","key":"1623_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/sj.pcan.4500257","volume":"1","author":"EA Klein","year":"1998","unstructured":"Klein EA, Kupelian PA, Witte JS. Does a family history of prostate cancer result in more aggressive disease? Prostate Cancer Prostatic Dis. 1998;1(6):297\u2013300.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"1623_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/diagnostics8030062","volume":"8","author":"AK Angeles","year":"2018","unstructured":"Angeles AK, Bauer S, Ratz L, Klauck SM, S\u00fcltmann H. Genome-Based Classification and Therapy of Prostate Cancer. Diagnostics (Basel). 2018;8(3):62.","journal-title":"Diagnostics (Basel)"},{"key":"1623_CR15","doi-asserted-by":"crossref","unstructured":"Trigos AS, Pasam A, Banks P, Wallace R, Guo C, Keam S, Thorne H; kConFab; Mitchell C, Lade S, Clouston D, Hakansson A, Liu Y, Blyth B, Murphy D, Lawrentschuk N, Bolton D, Moon D, Darcy P, Haupt Y, Williams SG, Castro E, Olmos D, Goode D, Neeson P, Sandhu S. Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes. J Immunother Cancer. 2022;10(6):e003744.","DOI":"10.1136\/jitc-2021-003744"},{"issue":"1","key":"1623_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13059-023-03074-w","volume":"24","author":"Y van der Pol","year":"2023","unstructured":"van der Pol Y, Moldovan N, Ramaker J, Bootsma S, Lenos KJ, Vermeulen L, Sandhu S, Bahce I, Pegtel DM, Wong SQ, Dawson SJ, Chandrananda D, Mouliere F. The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection. Genome Biol. 2023;24(1):229.","journal-title":"Genome Biol"},{"issue":"18","key":"1623_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad705","volume":"51","author":"X Zhong","year":"2023","unstructured":"Zhong X, Luan J, Yu A, Lee-Hassett A, Miao Y, Yang L. SFyNCS detects oncogenic fusions involving non-coding sequences in cancer. Nucleic Acids Res. 2023;51(18): e96.","journal-title":"Nucleic Acids Res"},{"key":"1623_CR18","doi-asserted-by":"crossref","unstructured":"Wang J, Jiang L, Shang Z, Ye Z, Yuan D, Cui X. A prognostic model for prostate cancer patients based on two DNA damage response mutation-related immune genes. Cancer Biother Radiopharm. 2024;39(4):306\u201317.","DOI":"10.1089\/cbr.2023.0033"},{"issue":"15","key":"1623_CR19","doi-asserted-by":"publisher","first-page":"12436","DOI":"10.3390\/ijms241512436","volume":"24","author":"MC Cursano","year":"2023","unstructured":"Cursano MC, Giunta EF, Scarpi E, Casadei C, Virga A, Ulivi P, Bleve S, Brighi N, Ravaglia G, Pantano F, Conteduca V, Santini D, De Giorgi U. Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer. Int J Mol Sci. 2023;24(15):12436.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1623_CR20","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.3390\/cancers15153998","volume":"15","author":"S Bang","year":"2023","unstructured":"Bang S, Won D, Shin S, Cho KS, Park JW, Lee J, Choi YD, Kang S, Lee ST, Choi JR, Han H. Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression. Cancers (Basel). 2023;15(15):3998.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1623_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112840","volume":"42","author":"SL Schuster","year":"2023","unstructured":"Schuster SL, Arora S, Wladyka CL, Itagi P, Corey L, Young D, Stackhouse BL, Kollath L, Wu QV, Corey E, True LD, Ha G, Paddison PJ, Hsieh AC. Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3\u2019 untranslated region mutations. Cell Rep. 2023;42(8): 112840.","journal-title":"Cell Rep"},{"key":"1623_CR22","doi-asserted-by":"crossref","unstructured":"Cussenot O, Cancel-Tassin G, Rao SR, Woodcock DJ, Lamb AD, Mills IG, Hamdy FC. Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice? BJU Int. 2023;132(5):472\u201384.","DOI":"10.1111\/bju.16120"},{"issue":"1","key":"1623_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00345-024-04937-y","volume":"42","author":"L Lin","year":"2024","unstructured":"Lin L, Ma Y, Li Z, Liu L, Hu Q, Zhou L. Genetic susceptibility of urolithiasis: comprehensive results from genome-wide analysis. World J Urol. 2024;42(1):230.","journal-title":"World J Urol"},{"issue":"1","key":"1623_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s42003-024-06114-8","volume":"7","author":"L Lin","year":"2024","unstructured":"Lin L, Tang Y, Ning K, Li X, Hu X. Investigating the causal associations between metabolic biomarkers and the risk of kidney cancer. Commun Biol. 2024;7(1):398.","journal-title":"Commun Biol"},{"key":"1623_CR25","doi-asserted-by":"crossref","unstructured":"GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318\u20131330.","DOI":"10.1126\/science.aaz1776"},{"issue":"3","key":"1623_CR26","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11(3):R25.","journal-title":"Genome Biol"},{"issue":"7726","key":"1623_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O\u2019Connell J, Cortes A, Welsh S, Young A, Effingham M, McVean G, Leslie S, Allen N, Donnelly P, Marchini J. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"key":"1623_CR28","doi-asserted-by":"crossref","unstructured":"Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM Jr, Batra J, Chambers S, Moya L, Clements J, Horvath L, Tilley W, Risbridger GP, Gronberg H, Aly M, Nordstr\u00f6m T, Pharoah P, Pashayan N, Schleutker J, Tammela TLJ, Sipeky C, Auvinen A, Albanes D, Weinstein S, Wolk A, H\u00e5kansson N, West CML, Dunning AM, Burnet N, Mucci LA, Giovannucci E, Andriole GL, Cussenot O, Cancel-Tassin G, Koutros S, Beane Freeman LE, Sorensen KD, Orntoft TF, Borre M, Maehle L, Grindedal EM, Neal DE, Donovan JL, Hamdy FC, Martin RM, Travis RC, Key TJ, Hamilton RJ, Fleshner NE, Finelli A, Ingles SA, Stern MC, Rosenstein BS, Kerns SL, Ostrer H, Lu YJ, Zhang HW, Feng N, Mao X, Guo X, Wang G, Sun Z, Giles GG, Southey MC, MacInnis RJ, FitzGerald LM, Kibel AS, Drake BF, Vega A, G\u00f3mez-Caama\u00f1o A, Szulkin R, Eklund M, Kogevinas M, Llorca J, Casta\u00f1o-Vinyals G, Penney KL, Stampfer M, Park JY, Sellers TA, Lin HY, Stanford JL, Cybulski C, Wokolorczyk D, Lubinski J, Ostrander EA, Geybels MS, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, R\u00f8der MA, Iversen P, Brenner H, Cuk K, Holleczek B, Maier C, Luedeke M, Schnoeller T, Kim J, Logothetis CJ, John EM, Teixeira MR, Paulo P, Cardoso M, Neuhausen SL, Steele L, Ding YC, De Ruyck K, De Meerleer G, Ost P, Razack A, Lim J, Teo SH, Lin DW, Newcomb LF, Lessel D, Gamulin M, Kulis T, Kaneva R, Usmani N, Singhal S, Slavov C, Mitev V, Parliament M, Claessens F, Joniau S, Van den Broeck T, Larkin S, Townsend PA, Aukim-Hastie C, Gago-Dominguez M, Castelao JE, Martinez ME, Roobol MJ, Jenster G, van Schaik RHN, Menegaux F, Truong T, Koudou YA, Xu J, Khaw KT, Cannon-Albright L, Pandha H, Michael A, Thibodeau SN, McDonnell SK, Schaid DJ, Lindstrom S, Turman C, Ma J, Hunter DJ, Riboli E, Siddiq A, Canzian F, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Cui Z, Kraft P, Amos CI, Conti DV, Easton DF, Wiklund F, Chanock SJ, Henderson BE, Kote-Jarai Z, Haiman CA, Eeles RA; Profile Study; Australian Prostate Cancer BioResource (APCB); IMPACT Study; Canary PASS Investigators; Breast and Prostate Cancer Cohort Consortium (BPC3); PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; Cancer of the Prostate in Sweden (CAPS); Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS); Genetic Associations and Mechanisms in Oncology (GAME-ON)\/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50(7):928\u2013936.","DOI":"10.1038\/s41588-018-0142-8"},{"key":"1623_CR29","doi-asserted-by":"crossref","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, Loukola A, Lahtela E, Mattsson H, Laiho P, Della Briotta Parolo P, Lehisto AA, Kanai M, Mars N, R\u00e4m\u00f6 J, Kiiskinen T, Heyne HO, Veerapen K, R\u00fceger S, Lemmel\u00e4 S, Zhou W, Ruotsalainen S, P\u00e4rn K, Hiekkalinna T, Koskelainen S, Paajanen T, Llorens V, Gracia-Tabuenca J, Siirtola H, Reis K, Elnahas AG, Sun B, Foley CN, Aalto-Set\u00e4l\u00e4 K, Alasoo K, Arvas M, Auro K, Biswas S, Bizaki-Vallaskangas A, Carpen O, Chen CY, Dada OA, Ding Z, Ehm MG, Eklund K, F\u00e4rkkil\u00e4 M, Finucane H, Ganna A, Ghazal A, Graham RR, Green EM, Hakanen A, Hautalahti M, Hedman \u00c5K, Hiltunen M, Hinttala R, Hovatta I, Hu X, Huertas-Vazquez A, Huilaja L, Hunkapiller J, Jacob H, Jensen JN, Joensuu H, John S, Julkunen V, Jung M, Junttila J, Kaarniranta K, K\u00e4h\u00f6nen M, Kajanne R, Kallio L, K\u00e4lvi\u00e4inen R, Kaprio J; FinnGen; Kerimov N, Kettunen J, Kilpel\u00e4inen E, Kilpi T, Klinger K, Kosma VM, Kuopio T, Kurra V, Laisk T, Laukkanen J, Lawless N, Liu A, Longerich S, M\u00e4gi R, M\u00e4kel\u00e4 J, M\u00e4kitie A, Malarstig A, Mannermaa A, Maranville J, Matakidou A, Meretoja T, Mozaffari SV, Niemi MEK, Niemi M, Niiranen T, O Donnell CJ, Obeidat ME, Okafo G, Ollila HM, Palom\u00e4ki A, Palotie T, Partanen J, Paul DS, Pelkonen M, Pendergrass RK, Petrovski S, Pitk\u00e4ranta A, Platt A, Pulford D, Punkka E, Pussinen P, Raghavan N, Rahimov F, Rajpal D, Renaud NA, Riley-Gillis B, Rodosthenous R, Saarentaus E, Salminen A, Salminen E, Salomaa V, Schleutker J, Serpi R, Shen HY, Siegel R, Silander K, Siltanen S, Soini S, Soininen H, Sul JH, Tachmazidou I, Tasanen K, Tienari P, Toppila-Salmi S, Tukiainen T, Tuomi T, Turunen JA, Ulirsch JC, Vaura F, Virolainen P, Waring J, Waterworth D, Yang R, Nelis M, Reigo A, Metspalu A, Milani L, Esko T, Fox C, Havulinna AS, Perola M, Ripatti S, Jalanko A, Laitinen T, M\u00e4kel\u00e4 TP, Plenge R, McCarthy M, Runz H, Daly MJ, Palotie A. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u2013518.","DOI":"10.1038\/s41586-022-05473-8"},{"key":"1623_CR30","doi-asserted-by":"crossref","unstructured":"Cunningham F, Allen JE, Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, Austine-Orimoloye O, Azov AG, Barnes I, Bennett R, Berry A, Bhai J, Bignell A, Billis K, Boddu S, Brooks L, Charkhchi M, Cummins C, Da Rin Fioretto L, Davidson C, Dodiya K, Donaldson S, El Houdaigui B, El Naboulsi T, Fatima R, Giron CG, Genez T, Martinez JG, Guijarro-Clarke C, Gymer A, Hardy M, Hollis Z, Hourlier T, Hunt T, Juettemann T, Kaikala V, Kay M, Lavidas I, Le T, Lemos D, Marug\u00e1n JC, Mohanan S, Mushtaq A, Naven M, Ogeh DN, Parker A, Parton A, Perry M, Pili\u017eota I, Prosovetskaia I, Sakthivel MP, Salam AIA, Schmitt BM, Schuilenburg H, Sheppard D, P\u00e9rez-Silva JG, Stark W, Steed E, Sutinen K, Sukumaran R, Sumathipala D, Suner MM, Szpak M, Thormann A, Tricomi FF, Urbina-G\u00f3mez D, Veidenberg A, Walsh TA, Walts B, Willhoft N, Winterbottom A, Wass E, Chakiachvili M, Flint B, Frankish A, Giorgetti S, Haggerty L, Hunt SE, IIsley GR, Loveland JE, Martin FJ, Moore B, Mudge JM, Muffato M, Perry E, Ruffier M, Tate J, Thybert D, Trevanion SJ, Dyer S, Harrison PW, Howe KL, Yates AD, Zerbino DR, Flicek P. Ensembl 2022. Nucleic Acids Res. 2022;50(D1):D988-D995.","DOI":"10.1093\/nar\/gkab1049"},{"issue":"1","key":"1623_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13098-024-01404-x","volume":"16","author":"X Zeng","year":"2024","unstructured":"Zeng X, Li Z, Lin L, Wei X. Assessment of glycemic susceptibility across multiple urological and reproductive disorders. Diabetol Metab Syndr. 2024;16(1):162.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"1623_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3797","volume":"40","author":"L Lin","year":"2024","unstructured":"Lin L, Ning K, Xiang L, Peng L, Li X. SGLT2 inhibition and three urological cancers: Up-to-date results. Diabetes Metab Res Rev. 2024;40(3): e3797.","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"1623_CR33","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s40618-023-02060-0","volume":"46","author":"L Lin","year":"2023","unstructured":"Lin L, Wang W, Xiao K, Guo X, Zhou L. Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. J Endocrinol Invest. 2023;46(10):2095\u2013102.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1623_CR34","first-page":"1961","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961\u201374.","journal-title":"Int J Epidemiol"},{"key":"1623_CR35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7: e34408.","journal-title":"Elife"},{"key":"1623_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fgene.2020.00157","volume":"11","author":"TA Myers","year":"2020","unstructured":"Myers TA, Chanock SJ, Machiela MJ. LDlinkR: An R Package for Rapidly Calculating Linkage Disequilibrium Statistics in Diverse Populations. Front Genet. 2020;11:157.","journal-title":"Front Genet"},{"issue":"6","key":"1623_CR37","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734\u20139.","journal-title":"Int J Epidemiol"},{"issue":"23","key":"1623_CR38","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1093\/bioinformatics\/btab665","volume":"37","author":"AE Murphy","year":"2021","unstructured":"Murphy AE, Schilder BM, Skene NG. MungeSumstats: a Bioconductor package for the standardization and quality control of many GWAS summary statistics. Bioinformatics. 2021;37(23):4593\u20136.","journal-title":"Bioinformatics"},{"issue":"2","key":"1623_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1623_CR40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"D1","key":"1623_CR41","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1623_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, Ketchum C, Armstrong J, Novak A, Pfeil J, Narkizian J, Deran AD, Musselman-Brown A, Schmidt H, Amstutz P, Craft B, Goldman M, Rosenbloom K, Cline M, O\u2019Connor B, Hanna M, Birger C, Kent WJ, Patterson DA, Joseph AD, Zhu J, Zaranek S, Getz G, Haussler D, Paten B. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1623_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","volume":"13","author":"H Song","year":"2022","unstructured":"Song H, Weinstein HNW, Allegakoen P, Wadsworth MH 2nd, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, Carroll PR, Wang B, Cooperberg MR, Shalek AK, Huang FW. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat Commun. 2022;13(1):141.","journal-title":"Nat Commun"},{"issue":"D1","key":"1623_CR44","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, Wang Y, Dong X, Sun D, Liu Z, Yue J, Wang H, Li T, Wang C. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51(D1):D1425\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1623_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5): e1004383.","journal-title":"PLoS Genet"},{"issue":"3","key":"1623_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/jnci\/djs486","volume":"105","author":"CA Haiman","year":"2013","unstructured":"Haiman CA, Stram DO, Vickers AJ, Wilkens LR, Braun K, Valtonen-Andr\u00e9 C, Peltola M, Pettersson K, Waters KM, Marchand LL, Kolonel LN, Henderson BE, Lilja H. Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations. J Natl Cancer Inst. 2013;105(3):237\u201343.","journal-title":"J Natl Cancer Inst"},{"key":"1623_CR47","doi-asserted-by":"publisher","first-page":"1166668","DOI":"10.3389\/fgene.2023.1166668","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Wang K. Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer. Front Genet. 2023;14:1166668.","journal-title":"Front Genet"},{"issue":"4","key":"1623_CR48","first-page":"1582","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen X, Li H, Liu B, Wang X, Zhou W, Wu G, Xu C. Identification and validation of MSMB as a critical gene for prostate cancer development in obese people. Am J Cancer Res. 2023;13(4):1582\u201393.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"1623_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1021\/acs.jproteome.1c00763","volume":"21","author":"T Lima","year":"2022","unstructured":"Lima T, Ferreira R, Freitas M, Henrique R, Vitorino R, Fardilha M. Integration of Automatic Text Mining and Genomic and Proteomic Analysis to Unravel Prostate Cancer Biomarkers. J Proteome Res. 2022;21(2):447\u201358.","journal-title":"J Proteome Res"},{"key":"1623_CR50","doi-asserted-by":"publisher","first-page":"8820366","DOI":"10.1155\/2021\/8820366","volume":"2021","author":"A Vezelis","year":"2021","unstructured":"Vezelis A, Simiene J, Dabkeviciene D, Kincius M, Ulys A, Suziedelis K, Jarmalaite S, Jankevicius F. LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer. J Oncol. 2021;2021:8820366.","journal-title":"J Oncol"},{"issue":"1","key":"1623_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12032-021-01461-6","volume":"38","author":"T Lima","year":"2021","unstructured":"Lima T, Henrique R, Vitorino R, Fardilha M. Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways. Med Oncol. 2021;38(1):9.","journal-title":"Med Oncol"},{"key":"1623_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145265","volume":"768","author":"X Wang","year":"2021","unstructured":"Wang X, Hayes JE, Xu X, Gao X, Mehta D, Lilja HG, Klein RJ. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR\/Cas9 mediated genome editing. Gene. 2021;768: 145265.","journal-title":"Gene"},{"issue":"8","key":"1623_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100344","volume":"3","author":"Y Wu","year":"2023","unstructured":"Wu Y, Qi T, Wray NR, Visscher PM, Zeng J, Yang J. Joint analysis of GWAS and multi-omics QTL summary statistics reveals a large fraction of GWAS signals shared with molecular phenotypes. Cell Genom. 2023;3(8): 100344.","journal-title":"Cell Genom"},{"issue":"3","key":"1623_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2020.07.038","volume":"79","author":"DJ Schaid","year":"2021","unstructured":"Schaid DJ, McDonnell SK, FitzGerald LM, DeRycke L, Fogarty Z, Giles GG, MacInnis RJ, Southey MC, Nguyen-Dumont T, Cancel-Tassin G, Cussenot O, Whittemore AS, Sieh W, Ioannidis NM, Hsieh CL, Stanford JL, Schleutker J, Cropp CD, Carpten J, Hoegel J, Eeles R, Kote-Jarai Z, Ackerman MJ, Klein CJ, Mandal D, Cooney KA, Bailey-Wilson JE, Helfand B, Catalona WJ, Wiklund F, Riska S, Bahetti S, Larson MC, Cannon Albright L, Teerlink C, Xu J, Isaacs W, Ostrander EA, Thibodeau SN. Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer. Eur Urol. 2021;79(3):353\u201361.","journal-title":"Eur Urol"},{"key":"1623_CR55","doi-asserted-by":"publisher","first-page":"5479279","DOI":"10.1155\/2020\/5479279","volume":"2020","author":"C Meng","year":"2020","unstructured":"Meng C, Xia S, He Y, Tang X, Zhang G, Zhou T. Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer. Comput Math Methods Med. 2020;2020:5479279.","journal-title":"Comput Math Methods Med"},{"issue":"5","key":"1623_CR56","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.3390\/ijms24054984","volume":"24","author":"NS Levy","year":"2023","unstructured":"Levy NS, Borisov V, Lache O, Levy AP. Molecular Insights into IQSEC2 Disease. Int J Mol Sci. 2023;24(5):4984.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1623_CR57","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1007\/s12010-021-03613-w","volume":"193","author":"S Sargazi","year":"2021","unstructured":"Sargazi S, Abghari AZ, Sarani H, Sheervalilou R, Mirinejad S, Saravani R, Eskandari E. Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis. Appl Biochem Biotechnol. 2021;193(12):4172\u201396.","journal-title":"Appl Biochem Biotechnol"},{"issue":"12","key":"1623_CR58","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.7150\/jca.51059","volume":"12","author":"JC Luan","year":"2021","unstructured":"Luan JC, Zhang QJ, Zhao K, Zhou X, Yao LY, Zhang TT, Zeng TY, Xia JD, Song NH. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy. J Cancer. 2021;12(12):3715\u201325.","journal-title":"J Cancer"},{"issue":"19","key":"1623_CR59","doi-asserted-by":"publisher","first-page":"10607","DOI":"10.3390\/ijms221910607","volume":"22","author":"O Howe","year":"2021","unstructured":"Howe O, White L, Cullen D, O\u2019Brien G, Shields L, Bryant J, Noone E, Bradshaw S, Finn M, Dunne M, Shannon AM, Armstrong J, McClean B, Meade A, Badie C, Lyng FM. A 4-Gene Signature of CDKN1, FDXR, SESN1 and PCNA Radiation Biomarkers for Prediction of Patient Radiosensitivity. Int J Mol Sci. 2021;22(19):10607.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1623_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13046-020-01815-4","volume":"40","author":"M Rauschner","year":"2021","unstructured":"Rauschner M, Lange L, H\u00fcsing T, Reime S, Nolze A, Maschek M, Thews O, Riemann A. Impact of the acidic environment on gene expression and functional parameters of tumors in vitro and in vivo. J Exp Clin Cancer Res. 2021;40(1):10.","journal-title":"J Exp Clin Cancer Res"},{"key":"1623_CR61","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2147\/CMAR.S281968","volume":"13","author":"J Ma","year":"2021","unstructured":"Ma J, Wei H, Li X, Qu X. Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17. Cancer Manag Res. 2021;13:2773\u201383.","journal-title":"Cancer Manag Res"},{"key":"1623_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euros.2023.08.001","volume":"55","author":"HY Hougen","year":"2023","unstructured":"Hougen HY, Graf RP, Li G, Quintanilha JCF, Lin DI, Ross JS, Punnen S, Mahal BA. Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer. Eur Urol Open Sci. 2023;55:45\u20139.","journal-title":"Eur Urol Open Sci"},{"key":"1623_CR63","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/978-1-4939-8873-0_36","volume":"1880","author":"D Kalamida","year":"2019","unstructured":"Kalamida D, Giatromanolaki A, Koukourakis MI. Characterization of the \u201cAutophagic Flux\u201d in Prostate Cancer Tissue Biopsies by LC3A\/LAMP2a Immunofluorescence and Confocal Microscopy. Methods Mol Biol. 2019;1880:555\u201360.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"1623_CR64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41419-018-0293-7","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Jiang F, He H, Ye J, Mao X, Guo Q, Wu SL, Zhong W, Wu CL, Lin N. Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer. Cell Death Dis. 2018;9(3):301.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1623_CR65","first-page":"5518","volume":"17","author":"X Li","year":"2018","unstructured":"Li X, Moon G, Shin S, Zhang B, Janknecht R. Cooperation between ETS variant 2 and Jumonji domain-containing 2 histone demethylases. Mol Med Rep. 2018;17(4):5518\u201327.","journal-title":"Mol Med Rep"},{"issue":"14","key":"1623_CR66","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/pros.24407","volume":"82","author":"S Casad\u00f3-Llombart","year":"2022","unstructured":"Casad\u00f3-Llombart S, Ajami T, Consuegra-Fern\u00e1ndez M, Carreras E, Aranda F, Armiger N, Alcaraz A, Mengual L, Lozano F. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution. Prostate. 2022;82(14):1331\u20137.","journal-title":"Prostate"},{"key":"1623_CR67","doi-asserted-by":"crossref","unstructured":"Spisak S, Tisza V, Nuzzo PV, Seo JH, Pataki B, Ribli D, Sztupinszki Z, Bell C, Rohanizadegan M, Stillman DR, Alaiwi SA, Bartels AB, Papp M, Shetty A, Abbasi F, Lin X, Lawrenson K, Gayther SA, Pomerantz M, Baca S, Solymosi N, Csabai I, Szallasi Z, Gusev A, Freedman ML. A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus. Nat Commun. 2023;14(1):5118.","DOI":"10.1038\/s41467-023-42515-9"},{"issue":"4","key":"1623_CR68","first-page":"759","volume":"14","author":"M Katoh","year":"2004","unstructured":"Katoh M, Katoh M. Characterization of human TMEM16G gene in silico. Int J Mol Med. 2004;14(4):759\u201364.","journal-title":"Int J Mol Med"},{"key":"1623_CR69","doi-asserted-by":"crossref","unstructured":"Wang M, Wisniewski CA, Xiong C, Chhoy P, Goel HL, Kumar A, Zhu LJ, Li R, St Louis PA, Ferreira LM, Pakula H, Xu Z, Loda M, Jiang Z, Brehm MA, Mercurio AM. Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer. Sci Transl Med. 2023;15(694):eade5855.","DOI":"10.1126\/scitranslmed.ade5855"},{"issue":"3","key":"1623_CR70","doi-asserted-by":"publisher","first-page":"500","DOI":"10.21037\/tcr-22-209","volume":"11","author":"W Yan","year":"2022","unstructured":"Yan W, Zeng Z, Qin F, Xu J, Liao Z, Ouyang M. Effects of brucine on mitochondrial apoptosis and expression of HSP70 in prostate cancer cells. Transl Cancer Res. 2022;11(3):500\u20137.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"1623_CR71","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/cimb44010027","volume":"44","author":"S Iacobas","year":"2022","unstructured":"Iacobas S, Iacobas DA. Personalized 3-Gene Panel for Prostate Cancer Target Therapy. Curr Issues Mol Biol. 2022;44(1):360\u201382.","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"1623_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41389-022-00382-x","volume":"11","author":"A Zabala-Letona","year":"2022","unstructured":"Zabala-Letona A, Arruabarrena-Aristorena A, Fernandez-Ruiz S, Viera C, Carlevaris O, Ercilla A, Mendizabal I, Martin T, Macchia A, Camacho L, Pujana-Vaquerizo M, Sanchez-Mosquera P, Torrano V, Martin-Martin N, Zuniga-Garcia P, Castillo-Martin M, Ugalde-Olano A, Loizaga-Iriarte A, Unda M, Mato JM, Berra E, Martinez-Chantar ML, Carracedo A. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer. Oncogenesis. 2022;11(1):10.","journal-title":"Oncogenesis"},{"key":"1623_CR73","doi-asserted-by":"crossref","unstructured":"Jamal K, Galbiati A, Armenia J, Illuzzi G, Hall J, Bentouati S, Barrell D, Ahdesm\u00e4ki M; Functional Genomics Centre Group; O\u2019Connor MJ, Leo E, Forment JV. Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition. Cancer Res Commun. 2022;2(10):1244\u20131254.","DOI":"10.1158\/2767-9764.CRC-22-0119"},{"key":"1623_CR74","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81083","volume":"11","author":"RA Cordova","year":"2022","unstructured":"Cordova RA, Misra J, Amin PH, Klunk AJ, Damayanti NP, Carlson KR, Elmendorf AJ, Kim HG, Mirek ET, Elzey BD, Miller MJ, Dong XC, Cheng L, Anthony TG, Pili R, Wek RC, Staschke KA. GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis. Elife. 2022;11: e81083.","journal-title":"Elife"},{"issue":"3","key":"1623_CR75","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/15548627.2022.2103961","volume":"19","author":"S Chouhan","year":"2023","unstructured":"Chouhan S, Sawant M, Weimholt C, Luo J, Sprung RW, Terrado M, Mueller DM, Earp HS, Mahajan NP. TNK2\/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability. Autophagy. 2023;19(3):1000\u201325.","journal-title":"Autophagy"},{"issue":"3","key":"1623_CR76","first-page":"287","volume":"38","author":"IM Grypari","year":"2023","unstructured":"Grypari IM, Pappa I, Papastergiou T, Zolota V, Bravou V, Melachrinou M, Megalooikonomou V, Tzelepi V. Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort dataset. Histol Histopathol. 2023;38(3):287\u2013302.","journal-title":"Histol Histopathol"},{"issue":"1","key":"1623_CR77","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1080\/21655979.2021.1965442","volume":"12","author":"H Huang","year":"2021","unstructured":"Huang H, Xu H, Li P, Ye X, Chen W, Chen W, Huang X. Zinc finger C3H1 domain-containing protein (ZFC3H1) evaluates the prognosis and treatment of prostate adenocarcinoma (PRAD): A study based on TCGA data. Bioengineered. 2021;12(1):5504\u201315.","journal-title":"Bioengineered"},{"issue":"1","key":"1623_CR78","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s42003-022-03385-x","volume":"5","author":"A Dhara","year":"2022","unstructured":"Dhara A, Aier I, Paladhi A, Varadwaj PK, Hira SK, Sen N. PGC1 alpha coactivates ERG fusion to drive antioxidant target genes under metabolic stress. Commun Biol. 2022;5(1):416.","journal-title":"Commun Biol"},{"issue":"1","key":"1623_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.6149","volume":"261","author":"FW Huang","year":"2023","unstructured":"Huang FW, Song H, Weinstein HN, Xie J, Cooperberg MR, Hicks J, Mummert L, De Marzo AM, Sfanos KS. Club-like cells in proliferative inflammatory atrophy of the prostate. J Pathol. 2023;261(1):85\u201395.","journal-title":"J Pathol"},{"issue":"38","key":"1623_CR80","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1038\/onc.2013.412","volume":"33","author":"CH Tsai","year":"2014","unstructured":"Tsai CH, Teng CH, Tu YT, Cheng TS, Wu SR, Ko CJ, Shyu HY, Lan SW, Huang HP, Tzeng SF, Johnson MD, Lin CY, Hsiao PW, Lee MS. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. Oncogene. 2014;33(38):4643\u201352.","journal-title":"Oncogene"},{"key":"1623_CR81","first-page":"1909196","volume":"2022","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang Y, Dong Y, Liu L, Han Y, Wang H, Wei Q, Xia P, Ma W, Li L. Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network. Dis Markers. 2022;2022:1909196.","journal-title":"Dis Markers"},{"issue":"9","key":"1623_CR82","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.ajpath.2023.05.012","volume":"193","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li W, Guo S, Wu Z, Zhang L, Liu Y, Li X, Guo X, Cao J, Yang C, Wang Z. FBXO22 Mediates the NGF\/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer. Am J Pathol. 2023;193(9):1248\u201366.","journal-title":"Am J Pathol"},{"issue":"16","key":"1623_CR83","doi-asserted-by":"publisher","first-page":"8792","DOI":"10.3390\/ijms22168792","volume":"22","author":"N Ren","year":"2021","unstructured":"Ren N, Liu Q, Yan L, Huang Q. Parallel Reporter Assays Identify Altered Regulatory Role of rs684232 in Leading to Prostate Cancer Predisposition. Int J Mol Sci. 2021;22(16):8792.","journal-title":"Int J Mol Sci"},{"key":"1623_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154317","volume":"243","author":"Z Yin","year":"2023","unstructured":"Yin Z, Zhang L, Liu R, Tong L, Jiang C, Kang L. Circ_0057558 accelerates the development of prostate cancer through miR-1238-3p\/SEPT2 axis. Pathol Res Pract. 2023;243: 154317.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"1623_CR85","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/1535-7163.MCT-20-0244","volume":"20","author":"SE Kohrt","year":"2021","unstructured":"Kohrt SE, Awadallah WN, Phillips RA 3rd, Case TC, Jin R, Nanda JS, Yu X, Clark PE, Yi Y, Matusik RJ, Anderson PD, Grabowska MM. Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro. Mol Cancer Ther. 2021;20(2):398\u2013409.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"1623_CR86","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1142\/S0192415X2350060X","volume":"51","author":"HY Kim","year":"2023","unstructured":"Kim HY, Lee SW, Choi SK, Ashim J, Kim W, Beak SM, Park JK, Han JE, Cho GJ, Ryoo ZY, Jeong J, Lee YH, Jeong H, Yu W, Park S. Veratramine Inhibits the Cell Cycle Progression, Migration, and Invasion via ATM\/ATR Pathway in Androgen-Independent Prostate Cancer. Am J Chin Med. 2023;51(5):1309\u201333.","journal-title":"Am J Chin Med"},{"key":"1623_CR87","doi-asserted-by":"crossref","unstructured":"Tian Y, Dong D, Wang Z, Wu L, Park JY; PRACTICAL consortium; Wei GH, Wang L. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression. Am J Hum Genet. 2023;110(8):1289\u20131303.","DOI":"10.1016\/j.ajhg.2023.07.003"},{"issue":"1","key":"1623_CR88","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1038\/s41467-022-34994-z","volume":"13","author":"N Giannareas","year":"2022","unstructured":"Giannareas N, Zhang Q, Yang X, Na R, Tian Y, Yang Y, Ruan X, Huang D, Yang X, Wang C, Zhang P, Manninen A, Wang L, Wei GH. Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG. Nat Commun. 2022;13(1):7320.","journal-title":"Nat Commun"},{"key":"1623_CR89","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12935-020-01577-1","volume":"20","author":"E Ma","year":"2020","unstructured":"Ma E, Wang Q, Li J, Zhang X, Guo Z, Yang X. LINC01006 facilitates cell proliferation, migration and invasion in prostate cancer through targeting miR-34a-5p to up-regulate DAAM1. Cancer Cell Int. 2020;20:515.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"1623_CR90","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ajpath.2010.10.002","volume":"178","author":"P Vainio","year":"2011","unstructured":"Vainio P, Gupta S, Ketola K, Mirtti T, Mpindi JP, Kohonen P, Fey V, Per\u00e4l\u00e4 M, Smit F, Verhaegh G, Schalken J, Alanen KA, Kallioniemi O, Iljin K. Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer. Am J Pathol. 2011;178(2):525\u201336.","journal-title":"Am J Pathol"},{"issue":"8","key":"1623_CR91","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.3390\/ijms24087594","volume":"24","author":"MA Manca","year":"2023","unstructured":"Manca MA, Scarpa F, Cossu D, Simula ER, Sanna D, Ruberto S, Noli M, Ashraf H, Solinas T, Madonia M, Cusano R, Sechi LA. A Multigene-Panel Study Identifies Single Nucleotide Polymorphisms Associated with Prostate Cancer Risk. Int J Mol Sci. 2023;24(8):7594.","journal-title":"Int J Mol Sci"},{"key":"1623_CR92","first-page":"8227806","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Kong X, Xin S, Bi L, Sun X. Discovery of Lipid Metabolism-Related Genes for Predicting Tumor Immune Microenvironment Status and Prognosis in Prostate Cancer. J Oncol. 2022;2022:8227806.","journal-title":"J Oncol"},{"issue":"3","key":"1623_CR93","first-page":"3474","volume":"8","author":"W Li","year":"2015","unstructured":"Li W, Gu M. NUDT11 rs5945572 polymorphism and prostate cancer risk: a meta-analysis. Int J Clin Exp Med. 2015;8(3):3474\u201381.","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"1623_CR94","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1464-410X.2012.11492.x","volume":"111","author":"G Orozco","year":"2013","unstructured":"Orozco G, Goh CL, Al Olama AA, Benlloch-Garcia S, Govindasami K, Guy M, Muir KR, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Kote-Jarai Z, Easton DF, Eyre S, Eeles RA. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. BJU Int. 2013;111(7):1148\u201355.","journal-title":"BJU Int"},{"issue":"5","key":"1623_CR95","first-page":"1303","volume":"39","author":"L Vanella","year":"2011","unstructured":"Vanella L, Di Giacomo C, Acquaviva R, Santangelo R, Cardile V, Barbagallo I, Abraham NG, Sorrenti V. The DDAH\/NOS pathway in human prostatic cancer cell lines: antiangiogenic effect of L-NAME. Int J Oncol. 2011;39(5):1303\u201310.","journal-title":"Int J Oncol"},{"issue":"1\u20132","key":"1623_CR96","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10735-004-3840-8","volume":"36","author":"PT Jubinsky","year":"2005","unstructured":"Jubinsky PT, Short MK, Mutema G, Morris RE, Ciraolo GM, Li M. Magmas expression in neoplastic human prostate. J Mol Histol. 2005;36(1\u20132):69\u201375.","journal-title":"J Mol Histol"},{"issue":"5","key":"1623_CR97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12032-021-01494-x","volume":"38","author":"LG Kostecka","year":"2021","unstructured":"Kostecka LG, Olseen A, Kang K, Torga G, Pienta KJ, Amend SR. High KIFC1 expression is associated with poor prognosis in prostate cancer. Med Oncol. 2021;38(5):47.","journal-title":"Med Oncol"},{"issue":"7","key":"1623_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/and.14079","volume":"53","author":"Y Peng","year":"2021","unstructured":"Peng Y, Dong S, Yang Z, Song Y, Ding J, Hou D, Wang L, Zhang Z, Li N, Wang H. Identification of docetaxel-related biomarkers for prostate cancer. Andrologia. 2021;53(7): e14079.","journal-title":"Andrologia"},{"issue":"5","key":"1623_CR99","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1158\/1535-7163.MCT-22-0676","volume":"22","author":"G Rossmueller","year":"2023","unstructured":"Rossmueller G, Mirkina I, Maurer B, Hoeld V, Mayer J, Thiele M, Kerschbaumer RJ, Schinagl A. Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic. Mol Cancer Ther. 2023;22(5):555\u201369.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"1623_CR100","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/CEJ.0000000000000359","volume":"27","author":"EK Choe","year":"2018","unstructured":"Choe EK, Lee Y, Cho JY, Choi SH, Park B, Lee JE, Cho EY. Search for genetic factor association with cancer-free prostate-specific antigen level elevation on the basis of a genome-wide association study in the Korean population. Eur J Cancer Prev. 2018;27(5):453\u201360.","journal-title":"Eur J Cancer Prev"},{"key":"1623_CR101","unstructured":"Wang Z, Zhang Y, Deng Q, Zhang J, Wang X, Liang H. Integrative analysis of androgen receptor interactors aberrations and associated prognostic significance in prostate cancer. Urol J. 2023;20(5):318\u201328."}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01623-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T14:01:54Z","timestamp":1750514514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01623-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01623-8","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}